Search Tag: SARS-CoV-2 virus

IMAGING Management

FDA Amends Emergency Use Authorization for Hologic’s Aptima SARS-CoV-2 Assay

2020 06 Oct

Hologic, Inc.  announced today that its Aptima® SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in May, is now authorized for testing of individuals without symptoms or other reasons to suspect COVID-19 infection. This authorization follows an  announcement  last week... Read more

Executive Health Management

Siemens Healthineers Collaboration With CDC To Standardize SARS-CoV-2 Assays

2020 15 Sep

The collaboration will standardize SARS-CoV-2 assays by defining concentrations of antibodies to specific viral proteins to confer neutralization that could one day be extrapolated to thresholds considered sufficient to confer immunity. Standardization across manufacturers is also expected to improve patient care by enabling long-term antibody level... Read more

Executive Health Management

Siemens Healthineers Collaboration With CDC To Standardize SARS-CoV-2 Assays

2020 15 Sep

The collaboration will standardize SARS-CoV-2 assays by defining concentrations of antibodies to specific viral proteins to confer neutralization that could one day be extrapolated to thresholds considered sufficient to confer immunity. Standardization across manufacturers is also expected to improve patient care by enabling long-term antibody level... Read more

IMAGING Management

Hologic Launches Validated Pooling Protocol for COVID-19 Testing

2020 11 Aug

In Time of Extraordinary Need, New Protocol Expected to Help Laboratories Deliver Greater Quantities of Highly Accurate Molecular Test Results and Reduce Turnaround Times  Hologic, Inc.  announced today that it has validated use of its Aptima® and Panther Fusion® molecular diagnostic COVID-19 assays with pooled patient samples and completed... Read more

ICU Management

DOD to Fund a Clinical Trial of COVID-19 Treatment with ExThera’s Seraph 100 Blood Filter

2020 09 Jun

After encouraging preliminary results in the treatment of critically-ill COVID-19 patients at a military hospital in the United States and fourteen other hospitals in Europe, the Department of Defense has selected the Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) as one of its main interventions in a pivotal, US-based randomized controlled... Read more